[Staphylococcus nasal carriage and infection of central venous ports in oncology].
OBJECTIVE
To assess the risk of infection of either subcutaneously implanted central venous access devices or percutaneous central venous catheters inserted via a subcutaneous tunnel in cancer patients with a positive staphylococcal nasal carriage.


METHODS
Prospective study.


METHODS
The study included 266 patients undergoing cancer chemotherapy.


METHODS
A nasal swab was taken prior to insertion of the venous access device and the patients were followed over 30 days for the occurrence of a staphylococcal infection (hemoculture and device or site of insertion).


RESULTS
A nasal staphylococcal nasal carriage was found in 227 patients. Out of the 15 developing a device infection, a staphylococcal nasal colonization was existing in nine patients. Bacteriological screening a sensitivity of 60% and a specificity of 13%.


CONCLUSIONS
Bacteriological screening at the time of device insertion of a central venous access device is of no value for the detection of patients at risk of staphylococcal infection of the device.
Ranchère
J Y
JY
Département d'anesthésie-réanimation, centre de lutte contre le cancer Léon-Bérard, Lyon, France.
Gordiani
B
B
D002353:Carrier State; D002405:Catheterization, Central Venous; D002408:Catheters, Indwelling / Q000382:microbiology*; D004866:Equipment Contamination; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D009666:Nose / Q000382:microbiology; D011446:Prospective Studies; D012307:Risk Factors; D012680:Sensitivity and Specificity; D013203:Staphylococcal Infections / Q000382:microbiology*